Seattle Genetics, Inc. (SGEN) financial statements (2021 and earlier)

Company profile

Business Address 21823 30TH DRIVE SE
BOTHELL, WA 98021
State of Incorp. WA
Fiscal Year End December 31
SIC 2836 - Biological Products, Except Diagnostic Substances (benchmarking)
More info Complete financial analysis Financial benchmarking

Balance sheet (Statement of financial position) ($ in millions)

12/31/2020
12/31/2019
12/31/2018
12/31/2017
12/31/2016
12/31/2015
12/31/2014
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments2,55981141141358965057
Cash and cash equivalents5582757816110910257
Short-term investments2,001536332252480547 
Receivables32523614685625339
Inventory, net of allowances, customer advances and progress billings116865360685743
Inventory116865360685743
Other undisclosed current assets624443191612268
Total current assets:3,0621,177654577735771408
Noncurrent Assets
Operating lease, right-of-use asset6165
Property, plant and equipment197155104104635046
Long-term investments and receivables1015749 3063 
Long-term investments1015749 3063 
Intangible assets, net (including goodwill)558575575   3
Goodwill275275275    
Intangible assets, net (excluding goodwill)284300300   3
Other noncurrent assets2117712219711115
Other undisclosed noncurrent assets      (3)
Total noncurrent assets:9391,02985030110412451
TOTAL ASSETS:4,0012,2061,503878838895459
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities, including:3882591911331218878
Accounts payable78524429292117
Accrued liabilities310207147    
Employee-related liabilities   38302522
Other undisclosed accounts payable and accrued liabilities   65624238
Deferred revenue and credits34284648
Contract with customer, liability34
Other liabilities      3
Other undisclosed current liabilities      (3)
Total current liabilities:388259225167149134126
Noncurrent Liabilities
Long-term debt and lease obligation6268     
Operating lease, liability6268
Liabilities, other than long-term debt6334315371118
Deferred revenue and credits315371118
Other liabilities6334    
Other undisclosed noncurrent liabilities   3345
Total noncurrent liabilities:125704335675122
Total liabilities:513330229200204209248
Stockholders' equity
Stockholders' equity attributable to parent3,4881,8761,274678634686211
Common stock0000000
Additional paid in capital4,3573,3592,5981,8061,7011,6131,017
Accumulated other comprehensive income (loss)10(0)64(0)(1)(0)
Accumulated deficit(870)(1,483)(1,325)(1,193)(1,067)(927)(806)
Total stockholders' equity:3,4881,8761,274678634686211
TOTAL LIABILITIES AND EQUITY:4,0012,2061,503878838895459

Income statement (P&L) ($ in millions)

12/31/2020
12/31/2019
12/31/2018
12/31/2017
12/31/2016
12/31/2015
12/31/2014
Revenues2,176917655482418337287
Revenue, net482418337287
Cost of revenue(218)(18)(63)(35)(42)(37)(18)
Cost of goods and services sold(218) (18)(35)(28)(24)(18)
Gross profit:1,958898592447376299269
Operating expenses(1,361)(1,119)(852)(643)(519)(420)(347)
Other undisclosed operating income      0
Operating income (loss):597(221)(260)(196)(143)(121)(77)
Nonoperating income
(Investment Income, Nonoperating)
712637301
Other undisclosed income from continuing operations before equity method investments, income taxes12507    
Income (loss) from continuing operations before income taxes:616(159)(246)(159)(140)(120)(76)
Income tax expense (benefit)(2) 2433   
Net income (loss) available to common stockholders, diluted:614(159)(223)(126)(140)(120)(76)

Comprehensive Income ($ in millions)

12/31/2020
12/31/2019
12/31/2018
12/31/2017
12/31/2016
12/31/2015
12/31/2014
Net income (loss):614(159)(223)(126)(140)(120)(76)
Other comprehensive income (loss)000641(1) 
Comprehensive income (loss):614(158)(222)(62)(139)(121)(76)
Other undisclosed comprehensive loss, net of tax, attributable to parent      (0)
Comprehensive income (loss), net of tax, attributable to parent:614(158)(222)(62)(139)(121)(76)

Statements sources

The financial statements are based on the company's filings with the The U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: